Skip to main content
. 2020 Oct 19;8(2):137–147. doi: 10.1093/nop/npaa068

Table 4.

Concurrent Validity of The MD Anderson Symptom Inventory Subscales and Items Compared With European Organisation for Research and Treatment of Cancer–Quality of Life Questionnaire (EORTC) 30 and EORTC-Brain Tumor Module N20 Subscale Scores

MDASI-BT EORTC-QLQ30 and BN20 Pearson correlation
All items Global Health Status/QOL –.412
WAW Physical functioning –.624
REM Role functioning –.318
Affective Emotional functioning –.413
Cognitive Cognitive functioning –.532
Fatigue item Fatigue .576
GI Nausea and vomiting .635
Pain Pain .462
Shortness of breath Dyspnea .396
Sleep disturbance Insomnia .427
Lack of appetite Appetite loss .508
Change in bowel pattern Constipation .431
Change in bowel pattern Diarrhea .254
Change in vision Visual disorder .488
Difficulty speaking Communication deficit .576
Pain Headaches .586
Seizures Seizures .486
Drowsiness Drowsiness .471
Change in Appearance Hair loss .283
Weakness Weakness of legs .267

Abbreviations: EORTC-BN20, European Organisation for Research and Treatment of Cancer; GI, gastrointestinal; MDASI-BT, The MD Anderson Symptom Inventory Brain Tumor Module; REM–role functioning, relations with others, enjoyment of life, and mood; QOL, quality of life; WAW, walking, general activity, and work.

Higher scores in the functioning subscale of the EORTC-BN20 denote better outcome. Hence, the negative correlations. All correlations are significant at P less than .005.